STOCK TITAN

Bausch Health to Announce Fourth-Quarter and Full-Year 2022 Results on Feb. 23

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Bausch Health Companies Inc. (BHC) is set to announce its fourth-quarter and full-year financial results on February 23, 2023. The announcement will be followed by a conference call at 8:00 a.m. U.S. EST to discuss the results and provide a business update. Investors can access all related materials on the Investor Relations section of the Bausch Health website. A replay of the call will also be available there. Bausch Health operates globally, specializing in various pharmaceutical sectors, including gastroenterology, neurology, and eye health.

Positive
  • Scheduled announcement of fourth-quarter and full-year results may enhance investor confidence.
  • Conference call to provide timely business updates.
Negative
  • None.

LAVAL, QC / ACCESSWIRE / February 1, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release its fourth-quarter and full-year financial results on Thursday, Feb. 23, 2022. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.

Conference Call Details

Date:

Thurs., Feb. 23, 2023

Time:

8:00 a.m. U.S. EST

Webcast:

http://ir.bauschhealth.com/events-and-presentations

A replay of the conference call will be available on the investor relations website.

To participate in the live Q&A session, please register using this link to receive a PIN, which will be sent an hour before the conference call.

About Bausch Health

Bausch Health Companies Inc. (NYSE/TSX:BHC) is a global diversified pharmaceutical company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. With our leading durable brands, we are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.

###

Investor Contact: Mark Maico, ir@bauschhealth.com, (877) 281-6642 (toll-free)

Media Contact: Kevin Wiggins, corporate.communications@bauschhealth.com, (908) 541-3785

SOURCE: Bausch Health Companies Inc.



View source version on accesswire.com:
https://www.accesswire.com/737551/Bausch-Health-to-Announce-Fourth-Quarter-and-Full-Year-2022-Results-on-Feb-23

FAQ

When will Bausch Health announce its fourth-quarter and full-year results?

Bausch Health will announce its results on February 23, 2023.

What time is the Bausch Health conference call on February 23, 2023?

The conference call is scheduled for 8:00 a.m. U.S. EST.

Where can I find the materials for Bausch Health's conference call?

Materials will be available on the Investor Relations section of the Bausch Health website.

Will there be a replay of the Bausch Health conference call?

Yes, a replay will be available on the investor relations website.

Bausch Health Companies Inc.

NYSE:BHC

BHC Rankings

BHC Latest News

BHC Stock Data

3.17B
367.80M
11.08%
77.48%
3.27%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
QUEBEC